Resumen de A New Drug Reduces the Risk of Thrombosis in AF

Diane S. Aschenbrenner

• * Apixaban (Eliquis) is a newly approved anticoagulant used to prevent stroke and thrombus formation in patients with nonvalvular atrial fibrillation.

  * Like all anticoagulants, apixaban may produce bleeding, including serious bleeding episodes. Sudden discontinuation of the drug increases the risk of stroke.